NCT00606502 2021-03-05Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based TreatmentSpectrum Pharmaceuticals, IncPhase 2 Completed201 enrolled 12 charts
NCT00227019 2017-03-06Phase 2 Trial of Bevacizumab in Combination With PemetrexedStanford UniversityPhase 2 Completed16 enrolled 9 charts